New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

BACKGROUND: In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (CNS) relapse is uncommon but is nearly always fatal. This study aimed to determine the risk factors for CNS relapse in DLBCL patients and to evaluate the efficacy of rituximab and intrathecal chemotherapy pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Qing-Qing, Hu, Li-Yang, Geng, Qi-Rong, Chen, Jie, Lu, Zhen-Hai, Rao, Hui-Lan, Liu, Qing, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022242/
https://www.ncbi.nlm.nih.gov/pubmed/27624700
http://dx.doi.org/10.1186/s40880-016-0150-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022242/
https://www.ncbi.nlm.nih.gov/pubmed/27624700
http://dx.doi.org/10.1186/s40880-016-0150-y

Ejemplares similares